Johnson & Johnson: FDA approval of ICOTYDE (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide

Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE ...

Celldex Therapeutics Touts Barzolvolimab Phase III CSU Momentum, Lays Out 2026 Data Catalysts

Celldex Therapeutics (NASDAQ:CLDX) executives highlighted recent clinical progress and upcoming catalysts during a discussion at the Leerink Partners Global Healthcare Conference, with a major focus ...

Incyte at Barclays: Maps Post-Jakafi Growth With New Launches and Phase III Pipeline Push

Incyte (NASDAQ:INCY) executives outlined the company’s near-term launch priorities and mid-stage pipeline plans during a presentation at the Barclays conference, emphasizing a strategy to sustain ...
Kotaku

Tips & Guides

It can be tough getting to grips with Mega Crit's new deckbuilder, but we'll put you on the right track We'll answer your biggest questions about the gorgeous, massively hyped open-world game Wooper ...